Pages

▼
Friday, July 30, 2021

New relevant target for PARP inhibitor talazoparib

›
Researchers report the identification of a new target for the PARP inhibitor drug talazoparib and show that combination treatment with talaz...
Thursday, July 29, 2021

Heart cell protein could lead to new treatments for heart failure and recovery

›
A protein that helps regulate calcium signaling within heart cells could play a key role in preventing chronic heart failure, according to a...

Heart cell protein could lead to new treatments for heart failure and recovery

›
A protein that helps regulate calcium signaling within heart cells could play a key role in preventing chronic heart failure, according to a...
Wednesday, July 28, 2021

Seeking a unique treatment for lobular breast cancer

›
In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer -- which affects some 40,000 women a...

Postmenopausal women can dance their way to better health

›
Women often struggle with managing their weight and other health risk factors, such as high cholesterol, once they transition through menopa...

Seeking a unique treatment for lobular breast cancer

›
In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer -- which affects some 40,000 women a...

Postmenopausal women can dance their way to better health

›
Women often struggle with managing their weight and other health risk factors, such as high cholesterol, once they transition through menopa...

Seeking a unique treatment for lobular breast cancer

›
In an attempt to find out why the long-term outcomes are poorer for patients with lobular breast cancer -- which affects some 40,000 women a...
Thursday, July 22, 2021

New approach eradicates breast cancer in mice

›
A new approach to treating breast cancer kills 95 to 100 percent of cancer cells in mouse models of human estrogen-receptor-positive breast ...

New approach eradicates breast cancer in mice

›
A new approach to treating breast cancer kills 95 to 100 percent of cancer cells in mouse models of human estrogen-receptor-positive breast ...